Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.32
+0.58 (2.94%)
At close: Dec 5, 2025, 4:00 PM EST
20.90
+0.58 (2.85%)
After-hours: Dec 5, 2025, 7:09 PM EST

Syndax Pharmaceuticals Revenue

Syndax Pharmaceuticals had revenue of $45.87M in the quarter ending September 30, 2025, with 266.97% growth. This brings the company's revenue in the last twelve months to $111.55M, up 597.19% year-over-year. In the year 2024, Syndax Pharmaceuticals had annual revenue of $23.68M.

Revenue (ttm)
$111.55M
Revenue Growth
+597.19%
P/S Ratio
15.80
Revenue / Employee
$412,237
Employees
270
Market Cap
1.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202423.68M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021139.71M138.19M9,109.56%
Dec 31, 20201.52M--
Dec 31, 20191.52M--
Dec 31, 20181.52M-591.00K-28.04%
Dec 31, 20172.11M888.00K72.79%
Dec 31, 20161.22M593.00K94.58%
Dec 31, 2015627.00K--
Dec 31, 2014---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

SNDX News

More News